Response of Psychiatric Outpatients to the Great East Japan Earthquake

Status Completed

Clinical Trial Summary

Objective: Reports have described how hospitalized psychiatric patients respond to disasters; however, few reports have described the response to disaster among psychiatric outpatients, who have relatively mild disease in comparison with hospitalized, severely ill psychiatric patients. Here the investigators have analyzed the response to disaster among this under-studied population.

Method: The Great East Japan Earthquake on March 11, 2011, was a catastrophic disaster. The investigators studied psychiatric change among a population of psychiatric outpatients in Tochigi prefecture, located ~160 km (~100 miles) southeast of the Fukushima nuclear power plant, in an area that suffered moderate damage from the earthquake. A total of 328 psychiatric outpatients were enrolled and were grouped into the diagnostic categories F2 (schizophrenic, schizotypal, and delusional disorders), F3 (affective disorders), and F4 (neurotic, stress-related, and somatoform disorders). All diagnoses were made using International Classification of Diseases (ICD) 10 criteria. Changes in symptoms were measured as a change in psychotropic medication after the disaster.

Clinical Trial Description

Patient progress was determined by whether a change in medication was needed. We focused on psychotropic drug use, including the use of neuroleptics, antidepressants, and benzodiazepines, directly after the disaster on March 11, 2011. Changes in other psychotropic drugs that are prescribed less frequently, such as lithium or anticonvulsants, were not considered in this study. Changes in symptoms that did not require a need to change psychotropic medications were not considered as part of a patient's progress. Physicians rated the relationship between each change in psychotropic drug and the disaster as direct, indirect, or not relevant. Only when three physicians rated the relationship as direct did we consider the change in a patient's progress to be due to the earthquake. Worsening or improvement of symptoms was defined as a change in psychotropic medications as a result of the deterioration or improvement, respectively, of symptoms. The data were stratified by disease category and sex and analyzed using chi-square tests. ;

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Mood Disorders

Clinical Trial Details

NCT number	NCT01533064
Study type	Observational
Source	Ashikaga Red Cross Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 2011
Completion date	May 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05321602` - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder	Phase 1
Recruiting	`NCT05345392` - Brain, Emotions, and Mind-Wandering	N/A
Completed	`NCT05078450` - Mood Lifters Online for Graduate Students and Young Professionals	N/A
Not yet recruiting	`NCT04551027` - Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness	N/A
Recruiting	`NCT03088657` - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
Active, not recruiting	`NCT02542475` - Low Field Magnetic Stimulation: Open Label Study.	Phase 1/Phase 2
Completed	`NCT00916552` - Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder	Phase 2
Completed	`NCT00202514` - Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms	Phase 2/Phase 3
Completed	`NCT00217932` - Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings	Phase 2
Completed	`NCT00006517` - Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)	N/A
Terminated	`NCT03898843` - Assisted Animal Therapy: ReAnimal	N/A
Active, not recruiting	`NCT04358900` - Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
Recruiting	`NCT06360562` - Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)	N/A
Completed	`NCT05745103` - Optimizing Behavioral Healthcare Delivery Through Technology	N/A
Suspended	`NCT03715400` - Mobile Virtual Positive Experiences for Anhedonia	N/A
Enrolling by invitation	`NCT03736538` - Nitrous Oxide- Suicidal Ideation	Phase 1
Completed	`NCT04601545` - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method	N/A
Completed	`NCT02566980` - Biological Triggers of Depression in Pregnancy
Completed	`NCT03743844` - Psychosocial Intervention for Women With Mood Disorders Seeking Treatment for Obesity	N/A
Completed	`NCT05211063` - Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.